OCEA: Ocean Biomedical, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Ocean Biomedical, Inc. (OCEA) qat'iy FDA nazorati ostidagi universitet patentlarini tijoratlashtirishga tayanadi. GURU.Markets grafigidagi qiymat va foyda nisbati bozor kutganlarini vizuallashtiradi, bunda 0.00 qiymati joriy ko'rsatkich vazifasini o'taydi. O'sish potentsiali global sog'liqni saqlash uchun saraton va bezgak terapiyalariga asoslangan, noyob vaksina ishlanmalari esa barqaror royalti daromadlarini yaratish uchun asos bo'lib xizmat qiladi.
Ocean Biomedical, Inc. (OCEA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Ocean Biomedical, Inc.|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi oceanbiomedical.com|OCEA - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Ocean Bio|OCEA - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Ocean Biomedical|Tezkor likvidlik ko‘rsatkichi oceanbiomedical.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
OCEA - Sof foyda|Kutilayotgan sof foyda Ocean Biomedical, Inc.|OCEA - P/E multiplikatori|Forvard P/E multiplikatori Ocean Biomedical Corp|OCEA - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Ocean Bio|OCEA - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Ocean Biomedical|OCEA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi oceanbiomedical.com|OCEA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Ocean Biomedical, Inc.
Kompaniyaning umumiy tahlili:OCEA - Ocean Biomedical Inc
Klassik baholash Ocean Biomedical, Inc. (OCEA) uchun qiyindir, chunki kompaniya hozirgi vaqtda daromadli bo'lmagan saratonga qarshi dori vositalarining yuqori xavfli klinik sinovlariga e'tibor qaratgan. PEG momentum ko'rsatkichi bozor kapitalizatsiyasini kutilayotgan daromad o'sishi dinamikasi bilan solishtiradi, bunda birdan past qiymat aktivning qadrsizlanganini anglatadi; biroq, ushbu emitent uchun asosiy masala tashqi kapitalni jalb qilish qobiliyati bo'lib qolmoqda.
Ocean Biomedical, Inc. raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Pharvaris Pharma|ABCL: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori tourmalinebio.com|PGEN (Precigen) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pharming Group NV PHAR|PEG multiplikatori NKTR|PEG multiplikatori Upstream Pharma (UPB)|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOSS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KALV (KalVista Pharma)|SEPN: PEG multiplikatori|PVLA (Pieris Corp) - Narxning foydaga va o‘sish sur’atiga nisbati|SVRA (Savara Inc.) - PEG multiplikatori|rigel.com (RIGL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati AnaptysBio (ANAB)|ATXS - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|RAPT - Narx-foyda va o‘sish multiplikatori|Aerovate - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda aclaristx.com|KYTX: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TLSA|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori THTX|Narx-foyda va o‘sish multiplikatori avalotx.com AVTX|PEG multiplikatori ELDN (Eledon Pharmaceuticals, Inc.)|PEG multiplikatori Agenus, Inc. AGEN|CLYM - Narxning foydaga va o‘sish sur’atiga nisbati|ZURA: Narxning foydaga va o‘sish sur’atiga nisbati|ATYR (aTyr Pharma, Inc.) - Narx-foyda va o‘sish multiplikatori|Adagene Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|IMA (ImageneBio) - PEG multiplikatori|Shattuck Therapeutics (STTK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Equillium, Inc. (EQ)|connectbiopharm.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori IMUX (Immunic)|ATRA - Narx-foyda va o‘sish multiplikatori|IFRX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati X4 Pharmaceuticals Inc. XFOR|adicetbio.com (ACET) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Celularity (CELU)|INMB (INmune Bio, Inc.) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori barinthusbio.com (BRNS)|PEG multiplikatori KZR|SABS - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori AKTX (Akari Therapeutics plc)|PEG multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati GOVX|EDSA: PEG multiplikatori|iBio Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|PEG multiplikatori XTL Bio|Narxning foydaga va o‘sish sur’atiga nisbati Bolt Biotherapeutics (BOLT)|HCWB (hcwbiologics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Aptevo Therapeutics Inc. APVO|AIM - Narx-foyda va o‘sish multiplikatori|Aditxt Corp - PEG multiplikatori|GRI - PEG multiplikatori|XRTX (XORTX Therapeutics Inc.) - Narx-foyda va o‘sish multiplikatori|reshapelifesciences.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|REVB (Revelation Biosciences, Inc.) - PEG multiplikatori|Indaptus Therapeutics Inc (INDP) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Scinai (SCNI)|Narx-foyda va o‘sish multiplikatori calcimedica.com CALI|Narxning foydaga va o‘sish sur’atiga nisbati Affimed N.V. AFMD|ALLK - Narx-foyda va o‘sish multiplikatori|HOOK: Narx-foyda va o‘sish multiplikatori|IGMS - PEG multiplikatori|iTeos (ITOS) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|THRD (Third Harmonic Bio) - PEG multiplikatori
